Therapeutic Areas

Noven’s commercialized products and product development activities are principally focused in the areas of women’s health and mental health, including ADHD and schizophrenia.

Product Indication Regulatory Status Marketing Rights
SECUADO®
(asenapine) transdermal system

Full Prescribing Information
& BOXED WARNING
Schizophrenia in adults Marketed in United States Noven
DAYTRANA®
(methylphenidate transdermal system)

Full Prescribing Information
& Boxed WARNING
ADHD in children and adolescents
6-17 years old
Marketed in United States Noven
MINIVELLE®
(estradiol transdermal system)

Full Prescribing Information
& Boxed WARNING
Moderate to severe vasomotor symptoms due to menopause and prevention of postmenopausal osteoporosis Marketed in United States Noven
COMBIPATCH®
(estradiol/NETA transdermal system)

Full Prescribing Information
& Boxed WARNING
Moderate to severe vasomotor symptoms; moderate to severe vulvar and vaginal atrophy; treatment of hypoestrogenism Marketed in United States Noven
ESTRADIOL TRANSDERMAL SYSTEM

Full Prescribing Information
& Boxed WARNING
Moderate to severe vasomotor symptoms due to menopause and prevention of postmenopausal osteoporosis Marketed in United States Noven